HLA-A2-specific CAR CD4+ Tregs have greater regulatory GVHD abilities than polyclonal CD4+ Tregs (93), and accordingly, HLA-A2-specific CAR CD8+ Tregs are reported to prevent GVHD more effectively (94). This evidence concerns the gene CD4 and graft versus host disease.